Literature DB >> 6128518

Ketoconazole and cyclosporin.

H Dieperink, J Møller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128518     DOI: 10.1016/s0140-6736(82)91231-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Mechanism of the ketoconazole-cyclosporin interaction.

Authors:  E Ah-Sing; T W Poole; C Ioannides; L J King
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

4.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 5.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 6.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

7.  Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

Authors:  A D'mello; R Venkataramanan; M Satake; S Todo; S Takaya; R J Ptachcinski; G J Burckart; T E Starzl
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-06

8.  Reversal of daunorubicin resistance in P388/ADR cells by itraconazole.

Authors:  S Gupta; J Kim; S Gollapudi
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

9.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  L Vernillet; P Bertault-Peres; Y Berland; J Barradas; A Durand; M Olmer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

10.  Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.

Authors:  D J Back; J F Tjia
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.